Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation

Rhea-AI Summary

Bausch Health Companies Inc. (NYSE/TSX: BHC) has announced its presentation during the Annual Meeting of Shareholders held on June 21, 2022. The presentation highlights the company's diversified pharmaceutical operations, focusing on improving health outcomes through various products in gastroenterology, neurology, and eye health, primarily via its ownership of Bausch + Lomb. The company has also filed a Form 8-K detailing this presentation, available on its Investor Relations page, reinforcing its commitment to advancing global health.

Positive

• Presentation emphasizes diversified pharmaceutical operations.
• Focus on healthcare improvement through a range of products.

Negative

• None.

LAVAL, QC, June 21, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation on its business during the Company's Annual Meeting of Shareholders on June 21, 2022. The presentation will be available on the Investor Relations section of the Bausch Health website. The Company has filed a Form 8-K this morning, annexing this presentation.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our approximately 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Investor Contact:	Media Contact:
Christina Cheng	Lainie Keller
christina.cheng@bauschhealth.com	lainie.keller@bauschhealth.com
(514) 856-3855	(908) 927-1198
(877) 281-6642 (toll free)

  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-issues-form-8-k-for-2022-annual-meeting-of-shareholders-presentation-301571550.html

SOURCE Bausch Health Companies Inc.

FAQ

What was announced by Bausch Health on June 21, 2022?

Bausch Health announced its presentation during the Annual Meeting of Shareholders.

Where can I find Bausch Health's presentation from June 21, 2022?

The presentation is available on the Investor Relations section of the Bausch Health website.

What is the focus of Bausch Health's business according to the recent announcement?

Bausch Health focuses on improving health outcomes with products in gastroenterology, neurology, and eye health.

What document did Bausch Health file related to their Annual Meeting?

Bausch Health filed a Form 8-K detailing their Annual Meeting presentation.